The Ipilimumab Anti-CTLA-4 Biosimilar Antibody is a highly specific antibody designed for research applications involving cytotoxic T-lymphocyte associated antigen 4 (CTLA-4), a key immune checkpoint protein that plays a critical role in regulating the immune response. This antibody, produced through biosimilar technology, offers researchers a reliable tool for studying the function of CTLA-4 in various biological systems.With its high affinity and specificity for CTLA-4, this biosimilar antibody enables accurate detection and analysis of CTLA-4 expression in human samples, making it ideal for use in techniques such as immunohistochemistry and flow cytometry.
By targeting CTLA-4, researchers can gain valuable insights into immune regulation mechanisms and develop innovative approaches for the treatment of cancer and autoimmune diseases.The Ipilimumab Anti-CTLA-4 Biosimilar Antibody holds great promise for advancing our understanding of immune checkpoint pathways and developing novel immunotherapies. Its superior performance and reliability make it a valuable asset for researchers in the fields of oncology, immunology, and drug development. Unlock the potential of CTLA-4 research with this cutting-edge biosimilar antibody.
Product Name:
Ipilimumab (Anti-CTLA-4) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0022
Target:
CTLA-4
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BMS-734016, MDX-010, MDX-CTLA-4
Description:
Anti-CTLA4 Reference mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
